Anesiva's media center is designed to provide reporters with easy access to news about the company and its products for stories in development. If you don't find what you are looking for or need more information, please contact us.
| All Releases |
|---|
 |
Corgentech Plans Meeting With FDA to Discuss Registration Strategy Prior to Unblinding of Phase 3 Trial
Feb 24, 2005
|
68.5 KB
|
| |
SOUTH SAN FRANCISCO, Calif., Feb 24, 2005 /PRNewswire-FirstCall via COMTEX/ -- Corgentech Inc. (Nasdaq: CGTK) today announced its intention to meet with the Food and Drug Administration (FDA) prior to the unblinding and announcement of the clinical data from its Phase 3 trial of edifoligide (E2F Decoy) for coronary artery bypass graft (CABG) failu...
|
|
|
Corgentech Announces Fourth Quarter and Year-End 2004 Financial Results
Feb 3, 2005
|
82.5 KB
|
| |
SOUTH SAN FRANCISCO, Calif., Feb 03, 2005 /PRNewswire-FirstCall via COMTEX/ -- Corgentech Inc. (Nasdaq: CGTK) today reported financial results for the fourth quarter and year ended December 31, 2004.
"We look forward to releasing top-line results from our PREVENT IV, Phase 3 trial in coronary artery bypass graft (CABG) failure by the end of th...
|
|
|
Corgentech to Announce Fourth Quarter and Year-End 2004 Financial Results and Host Webcast Conference Call on February 3, 2005
Feb 1, 2005
|
69.8 KB
|
| |
SOUTH SAN FRANCISCO, Calif., Feb 01, 2005 /PRNewswire-FirstCall via COMTEX/ -- Corgentech Inc. (Nasdaq: CGTK), a biotechnology company, will announce financial results for the fourth quarter and year-end 2004 after the markets close on Thursday, February 3, 2005 and will hold a webcast teleconference at 4:30 p.m. EST that day. John McLaughlin, Cor...
|
|
|
Corgentech to Present at 17th Annual Piper Jaffray Health Care Conference
Jan 20, 2005
|
63.9 KB
|
| |
SOUTH SAN FRANCISCO, Calif., Jan 20, 2005 /PRNewswire-FirstCall via COMTEX/ -- Corgentech Inc. (Nasdaq: CGTK), a biotechnology company, today announced that John P. McLaughlin, the company's president and chief executive officer, will present at the 17th Annual Piper Jaffray Health Care Conference on Thursday, January 27th, 2005, at 8:30 a.m. East...
|
|
|
Corgentech Files Investigational New Drug Application to Begin Phase 1/2 Trial of New Drug Candidate for Eczema
Jan 12, 2005
|
70.8 KB
|
| |
SOUTH SAN FRANCISCO, Calif., Jan 12, 2005 /PRNewswire-FirstCall via COMTEX/ -- Corgentech Inc. (Nasdaq: CGTK) today announced that the company filed an investigational new drug application (IND) with the U.S. Food and Drug Administration (FDA) to begin a Phase1/2 clinical trial of its NF-kappaB Decoy (NF-kB Decoy) drug candidate for the treatment ...
|
|
|
Click here to download our most recent fact sheet.